DK1615626T3 - Tablet med farvet kerne - Google Patents
Tablet med farvet kerneInfo
- Publication number
- DK1615626T3 DK1615626T3 DK04729172.9T DK04729172T DK1615626T3 DK 1615626 T3 DK1615626 T3 DK 1615626T3 DK 04729172 T DK04729172 T DK 04729172T DK 1615626 T3 DK1615626 T3 DK 1615626T3
- Authority
- DK
- Denmark
- Prior art keywords
- core
- coating
- core tablet
- colored core
- colouring agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0309343 | 2003-04-24 | ||
PCT/IB2004/001702 WO2004093850A1 (en) | 2003-04-24 | 2004-04-23 | Tablet with coloured core |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1615626T3 true DK1615626T3 (da) | 2010-02-08 |
Family
ID=33306520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04729172.9T DK1615626T3 (da) | 2003-04-24 | 2004-04-23 | Tablet med farvet kerne |
Country Status (9)
Country | Link |
---|---|
US (1) | US20070148229A1 (da) |
EP (1) | EP1615626B1 (da) |
JP (1) | JP4908200B2 (da) |
AT (1) | ATE445393T1 (da) |
CY (1) | CY1109726T1 (da) |
DE (1) | DE602004023597D1 (da) |
DK (1) | DK1615626T3 (da) |
ES (1) | ES2335008T3 (da) |
WO (1) | WO2004093850A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004231362B2 (en) | 2003-04-24 | 2009-11-12 | Jagotec Ag | Delayed release tablet with defined core geometry |
CA2533150C (en) * | 2003-07-25 | 2013-03-12 | Warner Chilcott Company, Inc. | A doxycycline metal complex in a solid dosage form |
KR101363563B1 (ko) * | 2004-09-10 | 2014-02-14 | 자고텍 아게 | 활성성분의 부위 및 시간 제어적 위장관 방출 정제 |
DE102004043863A1 (de) * | 2004-09-10 | 2006-03-16 | Nitec Pharma Ag | Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum |
MX2009001248A (es) | 2006-08-03 | 2009-02-11 | Nitec Pharma Ag | Tratamiento con glucocorticoide de liberacion prolongada de enfermedad reumatoide. |
AU2010207740B2 (en) * | 2009-01-26 | 2016-06-16 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of asthma |
NZ582836A (en) * | 2009-01-30 | 2011-06-30 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage |
JP5818219B2 (ja) * | 2012-05-14 | 2015-11-18 | 塩野義製薬株式会社 | 6,7−不飽和−7−カルバモイルモルヒナン誘導体含有製剤 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB874586A (en) * | 1957-10-28 | 1961-08-10 | Upjohn Co | Improvements in or relating to therapeutic compositions and the manufacture thereof |
GB860708A (en) * | 1958-06-23 | 1961-02-08 | Sterling Drug Inc | Medicinal tablets comprising 4-aminoquinoline-type drugs and salicylates |
US3048526A (en) | 1958-08-04 | 1962-08-07 | Wander Company | Medicinal tablet |
GB972128A (en) * | 1960-01-21 | 1964-10-07 | Wellcome Found | Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets |
BE629982A (da) * | 1962-04-06 | |||
DE2445971A1 (de) * | 1974-09-24 | 1976-04-08 | Schering Ag | Arzneimittelwirkstofftraeger ii |
US4797288A (en) * | 1984-10-05 | 1989-01-10 | Warner-Lambert Company | Novel drug delivery system |
DE3720757A1 (de) * | 1987-06-24 | 1989-01-05 | Bayer Ag | Dhp-manteltablette |
GB8820353D0 (en) * | 1988-08-26 | 1988-09-28 | Staniforth J N | Controlled release tablet |
US5047246A (en) * | 1988-09-09 | 1991-09-10 | Bristol-Myers Company | Direct compression cyclophosphamide tablet |
DE3930770A1 (de) * | 1989-09-14 | 1991-03-28 | Wolfgang F Dr Schoener | Implantierbare katheter aus medizinisch vertraeglichem elastischen kunststoff |
US5310578A (en) * | 1990-09-17 | 1994-05-10 | Merck Patent Gesellschaft | Deposition of cosmetically functional material onto pigments and fillers |
DE4100920A1 (de) * | 1991-01-15 | 1992-07-16 | Degussa | Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer |
JPH04346929A (ja) * | 1991-05-22 | 1992-12-02 | Takada Seiyaku Kk | 光に安定なメシル酸ブロモクリプチン製剤 |
JPH0672861A (ja) * | 1992-07-09 | 1994-03-15 | Takeda Chem Ind Ltd | 着色固形製剤 |
GB9215908D0 (en) * | 1992-07-27 | 1992-09-09 | Wellcome Found | Water dispersible tablets |
WO1994008589A1 (en) * | 1992-10-09 | 1994-04-28 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of systemic lupus erythematosus with dehydroepiandrosterone |
TW272942B (da) * | 1993-02-10 | 1996-03-21 | Takeda Pharm Industry Co Ltd | |
JPH06256171A (ja) * | 1993-03-04 | 1994-09-13 | Shin Etsu Chem Co Ltd | セルロース系腸溶性コーチング剤 |
US5464633A (en) * | 1994-05-24 | 1995-11-07 | Jagotec Ag | Pharmaceutical tablets releasing the active substance after a definite period of time |
US5709880A (en) * | 1995-07-10 | 1998-01-20 | Buckman Laboratories International, Inc. | Method of making tabletized ionene polymers |
IT1276031B1 (it) * | 1995-10-31 | 1997-10-24 | Angelini Ricerche Spa | Composizione farmaceutica per il trattamento delle malattie autoimmuni |
HRP970493A2 (en) * | 1996-09-23 | 1998-08-31 | Wienman E. Phlips | Oral delayed immediate release medical formulation and method for preparing the same |
US5792476A (en) * | 1996-12-19 | 1998-08-11 | Abigo Medical Ab | Sustained release glucocorticoid pharmaceutical composition |
US6365185B1 (en) * | 1998-03-26 | 2002-04-02 | University Of Cincinnati | Self-destructing, controlled release peroral drug delivery system |
GB9905898D0 (en) * | 1999-03-15 | 1999-05-05 | Darwin Discovery Ltd | Controlled-dose formulation |
JP2001017121A (ja) * | 1999-07-05 | 2001-01-23 | Anpureenu Europe:Kk | 被覆粒体及びその製造方法 |
AR026148A1 (es) * | 2000-01-21 | 2003-01-29 | Osmotica Argentina S A | Dispositivo osmotico con pasaje preformado que aumenta de tamano |
US6720327B2 (en) * | 2000-09-27 | 2004-04-13 | Pharmacia Corporation | Lactone integrin antagonists |
US6620439B1 (en) * | 2000-10-03 | 2003-09-16 | Atul M. Mehta | Chrono delivery formulations and method of use thereof |
JP2002212104A (ja) * | 2000-11-17 | 2002-07-31 | Takeda Chem Ind Ltd | タルク/硫酸バリウム含有製剤 |
HUP0501071A3 (en) * | 2001-03-13 | 2007-06-28 | Penwest Pharmaceutical Co | Chronotherapeutic dosage forms |
EP1245227A1 (en) * | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
IN191028B (da) * | 2001-05-17 | 2003-09-13 | Sun Pharmaceutical Ind Ltd | |
NZ532568A (en) * | 2001-09-28 | 2005-07-29 | Mcneil Ppc Inc | Modified release dosage forms |
JP4336074B2 (ja) * | 2001-11-15 | 2009-09-30 | 三菱商事フードテック株式会社 | 色調および食感が良好な硬質糖衣錠剤 |
AU2004231362B2 (en) * | 2003-04-24 | 2009-11-12 | Jagotec Ag | Delayed release tablet with defined core geometry |
US8029822B2 (en) * | 2003-05-22 | 2011-10-04 | Osmotica Kereskedelmi és Seolgáltató KFT | Rupturing controlled release device having a preformed passageway |
DE102004043863A1 (de) * | 2004-09-10 | 2006-03-16 | Nitec Pharma Ag | Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum |
-
2004
- 2004-04-23 AT AT04729172T patent/ATE445393T1/de not_active IP Right Cessation
- 2004-04-23 ES ES04729172T patent/ES2335008T3/es not_active Expired - Lifetime
- 2004-04-23 JP JP2006506624A patent/JP4908200B2/ja not_active Expired - Fee Related
- 2004-04-23 WO PCT/IB2004/001702 patent/WO2004093850A1/en active Application Filing
- 2004-04-23 US US10/554,258 patent/US20070148229A1/en not_active Abandoned
- 2004-04-23 DK DK04729172.9T patent/DK1615626T3/da active
- 2004-04-23 EP EP04729172A patent/EP1615626B1/en not_active Expired - Lifetime
- 2004-04-23 DE DE602004023597T patent/DE602004023597D1/de not_active Expired - Lifetime
-
2010
- 2010-01-08 CY CY20101100024T patent/CY1109726T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1615626A1 (en) | 2006-01-18 |
JP4908200B2 (ja) | 2012-04-04 |
ATE445393T1 (de) | 2009-10-15 |
US20070148229A1 (en) | 2007-06-28 |
EP1615626B1 (en) | 2009-10-14 |
ES2335008T3 (es) | 2010-03-18 |
JP2006524230A (ja) | 2006-10-26 |
DE602004023597D1 (de) | 2009-11-26 |
WO2004093850A1 (en) | 2004-11-04 |
CY1109726T1 (el) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109726T1 (el) | Δισκιο εγχρωμου πυρηνα | |
HUP0203623A2 (hu) | Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása | |
AR064901A2 (es) | Una pelicula consumible adaptada para disolverse en la boca de un consumidor | |
BRPI0409623A (pt) | produto farmacêutico, método de preparação do mesmo e uso de substáncias na preparação do referido produto farmacêutico | |
AR021391A1 (es) | Inhaladores presurizados de dosis medidas (mdi) y su uso. | |
AR027091A1 (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
ES2185817T3 (es) | Formas de dosificacion farmaceutica oral que comprenden un inhibidor de las bombas de protones y un agente antiacido o alginato. | |
DOP2001000229A (es) | Forma de dosificación de fármaco activada por hidrogel | |
DE69918310D1 (de) | Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff | |
TR199701584T1 (xx) | Anestezi etkili yeni farmas�tik kompozisyon | |
UY27186A1 (es) | Formulación farmacéutica | |
UY28304A1 (es) | Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad | |
ATE430557T1 (de) | Liposomen | |
HUP0104709A2 (hu) | Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására | |
PT1212317E (pt) | Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes | |
BR0215404A (pt) | processo e dispositivo para reduzir dosagem terapêutica | |
AU2003280918A8 (en) | Rabbit skin comprising biological active substance and its use | |
ATE301999T1 (de) | Racecadotril enthaltende trockene pulverformulierung | |
DE60128263D1 (de) | Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung | |
BR0116972A (pt) | Métodos e dispositivos para administração de substâncias na camada intradérmica da pele para absorção sistêmica | |
ITBO930205A0 (it) | Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica. | |
TR200101970T2 (tr) | Solunum yollarì hastalìklarìnìn tedavisinde matriks metaloproteaz inhibitrleri olarak ikameli 4-biarilbutirik ve 5-biarilpentanoik asit trevlerinin kullanìlmasì | |
PT994887E (pt) | Glicosidos modificados composicoes que compreendem os mesmos e metodos para a sua utilizacao | |
HUP9700806A2 (hu) | Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására | |
BRPI0012553B8 (pt) | pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso |